Last Friday September 7th, Biomedal attended the Molecular Microbiology Congress organized by the Spanish Society of Microbiology, which took place in Zaragoza. The company presented the “Premio Biomedal” in its fifth edition, a biannual award to which those research works in Molecular Microbiology published as original articles between 2016 and 2017 in a journal included in the list provided by the Institute for Scientific Information. (ISI), performed totally or partially …Read More
Biomedal, S.L. participates in an European project funded by the 7th Framework Program: “Magic Bullet”. This project is coordinated by the Andalusian Healthcare Service (SAS) to optimize the treatment of a certain type of pneumonia disease caused by antibiotic multirresistant bacteria. This type of disease is ventilation associated pneumonia (VAP), commonly acquired in intensive care units all over Europe. Biomedal will develop a novel antimicrobial susceptibility method based on …Read More
Biomedal, S.L. participates in an European project funded by the 7th Framework Program: “Gaining Productivity, Cost Efficiency and Sustainability in the Downstream Processing of Bio Products by novel Integration and Intensification strategies” (INTENSO). It is a 7 million euros funded project which is led by the Jabobs University in Germany and counts with the co-participation of 16 companies and universities from 11 different countries. The duration of the project is …Read More
Biomedal will attend one of the most prominent events in the field of Biotechnology: The 2013 BIO International Convention, which will take place April 22 – 25 in Chicago, IL. Biomedal will present its Bio-innovation and will participate in many partnering sessions which offer a good scenario for technology transfer and commercial agreements.